» Factor X Deficient Plasma Immunodepleted

HEMOSTASIS COAGULATION ROUTINE LYOPHILIZED IMMUNODEPLETED DEFICIENT PLASMAS EXTRINSIC PATHWAY FACTOR X

Factor X Deficient Plasma Immunodepleted

Lyophilized plasmas

Plasma deficient for Factor X assay.

Factor X Deficient Plasma is lyophilized and immuno-depleted human plasma with coagulant activity < 1% for FX.

Access on the manufacturer's website TECHNOCLONE

Reference	4-5174006
Presentation	Vial
Format	5 x 1.0 mL
Number of assays	100
Quote

Price list, safety data sheets and notices are accessible to our registered customers.

Reference	Presentation	Format	Number of assays	Quote	Product sheet
4-5174006	Vial	5 x 1.0 mL	100

Price list, safety data sheets and notices are accessible to our registered customers.

Factor X (FX) is a glycoprotein synthesized by the liver, dependent on vitamin K. FX is involved in the common pathway of coagulation.
It is activated in FXa by the FT-FVIIa complex or by the FVIIIa-FIXa complex in the presence of phospholipids.
FXa is neutralized by TFPI and antithrombin.

- Deficient plasma of human origin, stabilized and lyophilized with an activity < 1% of the corresponding coagulation factor. All other coagulation factors have normal values.
- Deficient plasma obtained by immunoadsorption.
- The FX-deficient plasma is used for the FX assay by the one-step method using thromboplastin.

Deficient plasma can be aliquoted and frozen for 1 month at -20 °C after reconstitution.

- 5 vials x 1 mL lyophilized plasma

Coagulation Control A
Coagulation Control N
Coagulation Reference

	These kits are manufactured in accordance with the 98/79 EC directive for in vitro diagnostic devices. Only CE marked products can be used for diagnostic applications in Europe.
	These kits are intended for in vitro diagnostic use.
	These kits are for research use only and are not intended to be used for diagnostic procedures.
	Federal Drug Administration, FDA validates diagnostic kits for in vitro diagnostic use in the United States.
	Biological risk products.
	Storage between 2 and 8 ° C.
	Reactive in liquid form.
	Reactive in lyophilized form.
	Reactive in frozen form.
	Stability after opening at 2-8 ° C.
	Products that can be refrozen.
	Stability 12 months after refreezing at -20 ° C.
	Manufacturer.
	Importer
	Distributor.

HEMOSTASIS COAGULATION ROUTINE LYOPHILIZED IMMUNODEPLETED DEFICIENT PLASMAS EXTRINSIC PATHWAY FACTOR X